SCHEMBL20189887

SCHEMBL20189887

C=CC[C@@H](O)CNc1nccc(C(=O)Nc2cnc(F)cc2N2CCN(CC=C)CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 10/20 0.40
GSK3A P49840 4/20 0.39
GSK3B P49841 4/20 0.39
MAPK8 P45983 6/20 0.39
KDR P35968 1/20 0.35
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
SRPK1 Q96SB4 3/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
JAK2 O60674 1/20 0.31
PIM1 P11309 1/20 0.31
CDK2 P24941 1/20 0.31
TYK2 P29597 1/20 0.31
SYK P43405 1/20 0.31
CDK5 Q00535 1/20 0.31
PRKCQ Q04759 1/20 0.31
AURKB Q96GD4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29742325 1.00 MAPK10 (0.40) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL20209251 1.00 MAPK10 (0.40) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL29742200 0.92 MAPK10 (0.39) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL20189746 0.92 MAPK10 (0.39) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL20209722 0.92 MAPK10 (0.39) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL20190346 0.86 GSK3A (0.40) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL22028161 0.86 GSK3A (0.40) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL29742324 0.86 GSK3A (0.40) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL20189514 0.86 ADRA1D (0.42) MAPK10GSK3AGSK3BMAPK8KDR
SCHEMBL29742268 0.86 ADRA1D (0.42) MAPK10GSK3AGSK3BMAPK8KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544968-A1 PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS Bristol-Myers Squibb Company (US) 2019-10-02 EP disclosed
WO-2018098413-A1 PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-31 WO disclosed